Sites Rate Novo Nordisk, Roche and Amgen on Top
Posted by Michael Jay on Wed, Jun 08, 2011
RxTrials welcomes CenterWatch as a guest blogger who wrote the below post:
The following is excerpted from the article “Sites rate Novo Nordisk, Roche, Amgen on top” by Karyn Korieth and Annick Anderson, which appears in The CenterWatch Monthly, June 2011 issue.
A new CenterWatch survey shows sponsors have improved their relationships with investigative sites during the past three years as they increasingly focus on strategies to improve site quality and performance. Yet the average sponsor continues to fall below the performance expectations of sites in several critical areas, including project management and study initiation activities. more...